NOVARTIND Stock Chart & Stats
₹1494.10
₹4.10(0.28%)
―
--
Day’s Range― - ―
52-Week Range₹750.00 - ₹1,777.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
₹36.79B
Enterprise Value₹15.48K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)37.7
Beta0.36
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)13.04
Shares Outstanding24,690,796
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NOVARTIND FAQ
What was Novartis India Limited’s price range in the past 12 months?
Novartis India Limited lowest stock price was ₹750.00 and its highest was ₹1777.50 in the past 12 months.
What is Novartis India Limited’s market cap?
Novartis India Limited’s market cap is ₹36.79B.
When is Novartis India Limited’s upcoming earnings report date?
Novartis India Limited’s upcoming earnings report date is Nov 05, 2026 which is in 69 days.
How were Novartis India Limited’s earnings last quarter?
Novartis India Limited released its earnings results on Jul 23, 2026. The company reported ₹13.045 earnings per share for the quarter, beating the consensus estimate of N/A by ₹13.045.
Is Novartis India Limited overvalued?
According to Wall Street analysts Novartis India Limited’s price is currently Undervalued.
Does Novartis India Limited pay dividends?
Novartis India Limited pays a N/A dividend of ₹25 which represents an annual dividend yield of N/A. See more information on Novartis India Limited dividends here
What is Novartis India Limited’s EPS estimate?
Novartis India Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Novartis India Limited have?
Novartis India Limited has 24,690,796 shares outstanding.
What happened to Novartis India Limited’s price movement after its last earnings report?
Novartis India Limited reported an EPS of ₹13.045 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.772%.
Which hedge fund is a major shareholder of Novartis India Limited?
Currently, no hedge funds are holding shares in IN:NOVARTIND
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Novartis India Limited
Novartis India Limited, an Indian healthcare enterprise, provides a diverse range of pharmaceutical solutions. Its offerings include branded medications for conditions related to bone and pain management, calcium supplementation, women's health (gynecology), and neurological disorders. Furthermore, the company supplies generic drugs specifically for gynecological issues, anti-tuberculosis treatments, and anti-infective applications. Notable branded products within its portfolio comprise Tegrital and Exelon for central nervous system disorders, Voveran for pain and inflammation relief, and specialized transplantation/immunology drugs like Simulect, Certican, Myfortic, and Sandimmun Neoral. Established in 1947 and headquartered in Mumbai, India, Novartis India Limited operates as a subsidiary of Novartis AG.